RUNX2 and hepatocellular carcinoma: Considering the oncogenic role of miR-23a, the promotion of miR-23a expression by Runx2 plays a carcinogenic role in mouse HCC cells, as it does in several cancer types, including ovarian, breast, liver and prostate cancer37–40.